Acusphere reports positive Imagify results
Article Thumbnail ImageJanuary 22, 2009 -- Ultrasound contrast developer Acusphere said that its Imagify echocardiography contrast agent was found to be well tolerated in newly published research, along with offering comparable diagnostic performance to nuclear imaging.
Member Sign In:
MemberID or E-mail Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password: